Research Article
Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
Table 5
The genes that expressed differently between berberine group and control group (fold change
2.0,
).
| | Gene name | Description | GeneBank ID | Fold change | value -test |
| | SLC2A4 | Solute carrier family 2(GLUT4) | NM_009204 | 4.48 | .0081 | | MAPK8 | Mitogen-activated protein kinase 8(JNK) | NM_016700 | 13.15 | .0203 | | MAPK14 | Mitogen-activated protein kinase 14 | NM_011951 | 4.17 | .0171 | | PPARα | Peroxisome proliferator-activated receptor alpha | NM_011144 | 2.10 | .0316 | | PPAR | Peroxisome proliferator-activated receptor gamma | NM_011146 | 5.51 | .0412 | | CEBP | CCAAT/enhancer-binding protein, alpha | NM_011144 | 3.06 | .0385 | | PPARC1 | Peroxisome proliferative-activated receptor, gamma, coactivator 1 alpha(PGC) | NM_008904 | 2.70 | .0306 | | UCP2 | Uncoupling protein 2 | NM_011671 | 2.55 | .0480 | | RETN | RESISTIN | NM_022984 | 2.12 | .0059 | | HNF4 | Hepatic nuclear factor 4, alpha | NM_008261 | 2.12 | .0455 |
|
|
